HBeAg negative patients with chronic hepatitis B are less likely to have a biochemical breakthrough during lamivudine treatmentUS Akarca,F Gunsar,G Ersoz,T Ozacar,S Erensoy,M Akyildiz, E Kasap,S Akay,F Tekin,Z Karasu,Y Batur,T IlterJOURNAL OF HEPATOLOGY(2005)引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要